SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment-Reference-Cited by-同舟云学术

SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment

Published:2021-12-06 Issue: Volume: Page:1-8
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Egeli Damla Buket¹,Hanfstein Benjamin¹,Lauseker Michael²,Pfirrmann Markus²,Saussele Susanne¹,Baerlocher Gabriela M.³,Müller Martin C.⁴

Affiliation:

1. III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany

2. Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität München, Munich, Germany

3. Department of BioMedical Research and Department of Hematology and Central Hematology Department, Inselspital, University Hospital, University of Bern, Bern, Switzerland

4. Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany

Funder

German Government

Deutsche Krebshilfe

Deutsche José-Carreras Leukämiestiftung

European Union

Novartis Oncology, Nürnberg

Roche, Grenzach-Wyhlen; and Essex, Munich, Germany

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.2010059

Reference44 articles.

1. Chronische myeloische Leukämie

2. Chronische myeloische Leukämie

3. Chromosomal localization of human cellular homologues of two viral oncogenes

4. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

5. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Treatment of Chronic Myeloid Leukemia;Recent Patents on Anti-Cancer Drug Discovery;2024-02